Stay updated on Risankizumab in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.

Latest updates to the Risankizumab in Ulcerative Colitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s interface revision was updated from one ClinicalTrials.gov release to the next (v3.5.2 → v3.5.3), reflecting a site/version update rather than any change to the underlying trial history or record details.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision v3.5.2 was added and v3.5.0 was removed from the history.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2; this appears to be a software version update with no visible changes to content or layout.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page history shows an addition of Revision: v3.4.2 and deletion of Revision: v3.4.1. This is metadata about versioning and does not modify study data or user-visible content.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed from the history.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.